Emgality is a calcitonin gene-related peptide (CGRP) binding antibody studied in migraine and episodic cluster headache1
Emgality is a humanized monoclonal antibody that binds to CGRP and blocks its binding to the receptor1

There are no relevant data on the pharmacodynamic effects of galcanezumab-gnlm.1
See how Emgality works
Discover the efficacy of Emgality for patients with migraine or episodic cluster headache
Reference: 1.Emgality [Prescribing Information]. Indianapolis, IN: Lilly USA, LLC.